China’s medical insurance scheme extends coverage to rare‑disease patients, highlighting global human‑rights governance

China’s national medical insurance program now includes treatment for rare diseases. The policy change aims to improve access to costly therapies for affected patients. Officials say the move aligns with broader human‑rights commitments. The coverage expansion reduces out‑of‑pocket expenses for families. Critics note that implementation details remain unclear. International observers view the reform as a benchmark for other nations. The government plans to monitor the scheme’s impact on patient outcomes. Advocacy groups welcome the step but call for continued transparency.